Pharmacogenomics: Identification of New Drug Targets
Principles of Pharmacogenetics: Types of Genetic Variants
Type I Diabetes II: Pathophysiology
Genetic Screens
Diabetes Mellitus: Type 2 and Gestational
Genome-wide Association Studies-GWAS
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Apr 25, 2026

In Vivo Modeling of the Morbid Human Genome using Danio rerio
Published on: August 24, 2013
Quan Li1, Xiaoming Liu2, Richard A Gibbs3
1Endocrine Genetics Lab, The McGill University Health Center (Montreal Children's Hospital), Montréal, Québec, Canada.
Predicting mutations causing maturity-onset diabetes of the young (MODY) is crucial. This study compares bioinformatics tools, finding gene-specific thresholds improve accuracy for MODY molecular diagnosis.
06:41In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
Published on: August 20, 2019
08:04Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
Published on: June 6, 2025
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: